Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 3/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL57736 | 0.89 | ALDH1A1 (0.60) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| SCHEMBL29911025 | 0.89 | ALDH1A1 (0.60) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| SCHEMBL19025062 | 0.88 | ALDH1A1 (0.71) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| Bicarbonate SCHEMBL18955378 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| Bicarbonate SCHEMBL18955379 | 0.86 | ALDH1A1 (0.56) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| SCHEMBL8134133 | 0.85 | ALDH1A1 (0.53) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| SCHEMBL6257741 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| SCHEMBL5164726 | 0.83 | ALDH1A1 (0.50) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| SCHEMBL26622078 | 0.83 | ALDH1A1 (0.53) | ALDH1A1TDP1L3MBTL1RAB9APOLB | |
| SCHEMBL2475071 | 0.83 | ALDH1A1 (0.53) | ALDH1A1TDP1L3MBTL1RAB9APOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101495657-A | Nucleic Acid Amplification Using Reversibly Modified Oligonucleotides | WANLI BI (US) | 2009-07-29 | — | — | CN | claimed |
| US-20250361211-A1 | DEUTERATED CFTR POTENTIATORS | VERTEX PHARMACEUTICALS (EUROPE) LIMITED (GB) | 2025-11-27 | — | — | US | disclosed |
| EP-4259139-A1 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | Vertex Pharmaceuticals Incorporated (US) | 2023-10-18 | — | — | EP | disclosed |
| CN-116568677-A | piperidin-1-yl-N-pyridin-3-yl-2-oxoacetamide derivatives useful for the treatment of MTAP deficiency and/or MTA accumulating cancers | 探戈医药股份有限公司 | 2023-08-08 | — | — | CN | disclosed |
| WO-2022125826-A1 | METHODS OF TREATMENT FOR CYSTIC FIBROSIS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2022-06-16 | — | — | WO | disclosed |
| EP-2540697-B1 | METHOD FOR PRODUCING DIARYL CARBONATE | ASAHI CHEMICAL IND (JP) | 2022-04-20 | — | — | EP | disclosed |
| US-10894773-B2 | Deuterated CFTR potentiators | VERTEX PHARMACEUTICALS (EUROPE) LIMITED (GB) | 2021-01-19 | — | — | US | disclosed |
| EP-3538510-B1 | PROCESS FOR THE PREPARATION OF MONO-PROTECTED ALPHA,OMEGA-DIAMINO ALKANES | BYONDIS BV (NL) | 2021-01-06 | — | — | EP | disclosed |
| US-20200290971-A1 | DEUTERATED CFTR POTENTIATORS | VERTEX PHARMACEUTICALS (EUROPE) LIMITED (GB) | 2020-09-17 | — | — | US | disclosed |
| US-10479766-B2 | Deuterated CFTR potentiators | Verex Pharmaceuticals (Europe) Limited (GB) | 2019-11-19 | — | — | US | disclosed |
| CN-1265641-A | method for producing aromatic carbonates | ASAHI CHEMICAL IND (JP) | 2000-09-06 | — | — | CN | disclosed |
| EP-1016648-A1 | PROCESS FOR THE PREPARATION OF AROMATIC CARBONATES | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 2000-07-05 | — | — | EP | disclosed |
| US-5872275-A | Process for the producing of aromatic carbonate | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1999-02-16 | — | — | US | disclosed |
| EP-0855384-A1 | PROCESS FOR THE PREPARATION OF AROMATIC CARBONATE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1998-07-29 | — | — | EP | disclosed |
| CN-1159442-A | Method for preparation aromatic carbonic ether | GEN ELECTRIC (US) | 1997-09-17 | — | — | CN | disclosed |
| CN-1030073-C | Process for continuous production of aryl carbonate | ASAHI CHEMICAL IND (JP) | 1995-10-18 | — | — | CN | disclosed |
| EP-0461274-B1 | PROCESS FOR CONTINUOUSLY PRODUCING AROMATIC CARBONATE | ASAHI CHEMICAL IND (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-5210268-A | Ester interchange, catalysis | ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) | 1993-05-11 | — | — | US | disclosed |
| CN-1064677-A | PROCESS FOR PREPARING AROMATIC CARBONATE | ASAHI CHEMICAL IND (JP) | 1992-09-23 | — | — | CN | disclosed |
| EP-0461274-A1 | PROCESS FOR CONTINUOUSLY PRODUCING AROMATIC CARBONATE | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1991-12-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361211-A1 | DEUTERATED CFTR POTENTIATORS | CFTR, SLC26A3, SLC26A4 | ALDH1A1 1205/4885TDP1 2200/4885L3MBTL1 4514/4885 |
| US-20200290971-A1 | DEUTERATED CFTR POTENTIATORS | CFTR, SLC26A3, SLC26A4 | ALDH1A1 1205/4885TDP1 2200/4885L3MBTL1 4514/4885 |
| US-10479766-B2 | Deuterated CFTR potentiators | CFTR, SLC26A3, SLC26A4 | ALDH1A1 1205/4885TDP1 2200/4885L3MBTL1 4514/4885 |
| US-10894773-B2 | Deuterated CFTR potentiators | CFTR, SLC26A3, SLC26A4 | ALDH1A1 1205/4885TDP1 2200/4885L3MBTL1 4514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.